Track record · closed signal

Sprinklr, Inc. (CXM) — closed signal from September 22, 2025

Partial Published before the outcome was known, scored automatically when the window closed on December 21, 2025.

Predicted vs. what happened

CXM price · publication thesis → realized outcomesplit-adjusted
$7.81 Published $9.76 Target $7.84 Window close $8.21 Peak
$7.30 – $7.80Entry zone — fair-value band
$7.81Published — price the day we called it
$9.76Target — the price the thesis aimed for
$8.21Peak — highest point inside the window, not a realized return
$7.84Window close — end-of-window price, context only

What happened

Partial

Reached 20% of the predicted growth at its peak, without hitting the target.

Peak price
$8.21
peak on December 10, 2025 — not a realized return
Peak gain
+5.1%
peak, from the publication price
Window close
$7.84
end-of-window price, context only
Days to target
Window
September 22, 2025 – December 21, 2025

The thesis — published September 22, 2025

Predicted growth
+25%
over the measurement window
Target price
$9.76
the price the thesis aimed for
Entry zone
$7.30 – $7.80
the fair-value band we waited for
Price at publication
$7.81
published September 22, 2025
Confidence
64%
how strongly the data lined up
Timeframe
Short-term (0–3 months)

Sprinklr fell hard, but the drop looks overdone and early signs suggest buyers are returning. Q2 sales grew 7.5% and beat expectations by 3.2% (9/15). Plan: consider buying around $7.30-$7.80, then adding only if it clears $8.30 and interest improves. Over the next 0-3 months, reopened budgets, better profits, and a calmer mood could help the price rebound.

Primary drivers

  • Price looks washed out, and buying interest is starting to pick up
  • Quarter showed 7.5% sales growth and a 3.2% beat, profits improving
  • Investor mood stays fairly positive even after the recent drop
  • Many companies unlock software budgets soon, helping near-term sales

How it played out

CXM: rebound started, but the target was missed

On September 22, Lyra published a short-term rebound thesis on CXM at $7.81. It expected 25% growth. The thesis pointed to a washed-out price, buying interest starting to pick up, Q2 sales growth of 7.5%, a 3.2% beat, improving profits, fairly positive investor mood, and possible software budget reopening over the next 0-3 months.

Inside the window, CXM rose, but not enough. It peaked at $8.21 on December 10, with a 5.1% gain. It never reached the $9.76 target. The stock ended the window at $7.84. The thesis partially played out on direction, but it missed on magnitude.

Prices are shown split- and dividend-adjusted, matching what public charts show today.

Share this receipt

A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.

Lyra

Read the next call before it closes.

This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.